ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Studies have shown that adiponectin can activate anti-NAFLD by activating AMP-activated protein kinase (AMPK), a key kinase that regulates cellular energy homeostasis, via the AdipoR1-related pathway [9].